BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28915710)

  • 1. Insights from animal models of bladder cancer: recent advances, challenges, and opportunities.
    John BA; Said N
    Oncotarget; 2017 Aug; 8(34):57766-57781. PubMed ID: 28915710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current animal models of bladder cancer: Awareness of translatability (Review).
    Ding J; Xu D; Pan C; Ye M; Kang J; Bai Q; Qi J
    Exp Ther Med; 2014 Sep; 8(3):691-699. PubMed ID: 25120584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time cancer cell tracking by bioluminescence in a preclinical model of human bladder cancer growth and metastasis.
    van der Horst G; van Asten JJ; Figdor A; van den Hoogen C; Cheung H; Bevers RF; Pelger RC; van der Pluijm G
    Eur Urol; 2011 Aug; 60(2):337-43. PubMed ID: 21616583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer: translating molecular genetic insights into clinical practice.
    Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
    Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges with in vitro and in vivo experimental models of urinary bladder cancer for novel drug discovery.
    Oliveira PA; Gil da Costa RM; Vasconcelos-Nóbrega C; Arantes-Rodrigues R; Pinto-Leite R
    Expert Opin Drug Discov; 2016 Jun; 11(6):599-607. PubMed ID: 27077499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal Models in Bladder Cancer.
    Constantin T; Păvălean M; Bucur Ș; Constantin MM; Nicolescu AC; Pacu I; Mădan V
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse orthotopic models for bladder cancer research.
    Chan E; Patel A; Heston W; Larchian W
    BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress made in the use of animal models for the study of high-risk, nonmuscle invasive bladder cancer.
    Lin-Tsai O; Taylor JA; Clark PE; Adam RM; Wu XR; DeGraff DJ
    Curr Opin Urol; 2014 Sep; 24(5):512-6. PubMed ID: 24921908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological complexity of urothelial carcinoma: Insights into carcinogenesis, targets and biomarkers of response to therapeutic approaches.
    Grivas PD; Melas M; Papavassiliou AG
    Semin Cancer Biol; 2015 Dec; 35():125-32. PubMed ID: 26304731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor activation: a prospective therapeutic target for bladder cancer?
    Mizushima T; Tirador KA; Miyamoto H
    Expert Opin Ther Targets; 2017 Mar; 21(3):249-257. PubMed ID: 28064545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research.
    Schütte U; Bisht S; Brossart P; Feldmann G
    Expert Opin Drug Discov; 2011 Jan; 6(1):33-48. PubMed ID: 22646825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
    Kausch I; Böhle A
    Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for bladder cancer: The model establishment and evaluation (Review).
    Zhang N; Li D; Shao J; Wang X
    Oncol Lett; 2015 Apr; 9(4):1515-1519. PubMed ID: 25788992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.
    Flaig TW; Kamat AM; Hansel D; Ingersoll MA; Barton Grossman H; Mendelsohn C; DeGraff D; Liao JC; Taylor JA
    Bladder Cancer; 2017 Jul; 3(3):211-223. PubMed ID: 28824949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-based molecular markers for bladder cancer.
    Barbieri CE; Lotan Y; Lee RK; Sonpavde G; Karakiewicz PI; Robinson B; Scherr DS; Shariat SF
    Minerva Urol Nefrol; 2010 Sep; 62(3):241-58. PubMed ID: 20940694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational research challenges: finding the right animal models.
    Prabhakar S
    J Investig Med; 2012 Dec; 60(8):1141-6. PubMed ID: 23072902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans.
    Tsamouri MM; Steele TM; Mudryj M; Kent MS; Ghosh PM
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
    Zhang H; Fan Y; Xia L; Gao C; Tong X; Wang H; Sun L; Ji T; Jin M; Gu B; Fan B
    Tumour Biol; 2017 Mar; 39(3):1010428317691183. PubMed ID: 28345451
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.